Immunicom Competitors and Similar CompaniesClear all
Immunicom's competitors and similar companies include IO Biotech and MaxCyte.
 Immunicom Immunicom is a company that develops and commercializes a non-drug-based cancer therapy in order to reduce treatment side effects and enhance its response rates. |  IO Biotech IO Biotech is a clinical-stage biotech company developing immune-modulating cancer therapies. |  MaxCyte MaxCyte (formerly known as Theramed) is a cell engineering company focused on providing platform technologies for cell-based research as well as cell therapeutic discovery, development, and commercialization. | |
Founding Date | Founding Date 2013 | Founding Date 2014 | Founding Date 1998 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations San Diego, US HQ | Locations New York, US HQ København, DK Usk, GB Rockville, US | Locations Gaithersburg, US HQ Alderley Edge, GB |
Employees | Employees 22 | Employees 19 | Employees 65 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 85.3 m | Valuation ($) 387.9 m |
Financial | |||
Net income | Net income N/A | Net income ($95.5m) (FY, 2024) | Net income ($44.6m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 21.9m | Total funding raised $ 165.9m | Total funding raised $ 31.3m |
For sources of this data, please see the company profile
View Company Profiles
IO Biotech
HQ
New York, US
Employees
19
IO Biotech is a clinical-stage biotech company developing immune-modulating cancer therapies.
View companyMaxCyte
HQ
Gaithersburg, US
Employees
65
MaxCyte (formerly known as Theramed) is a cell engineering company focused on providing platform technologies for cell-based research as well as cell therapeutic discovery, development, and commercialization.
View company